Unclot 2.5 Tablet
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Rivaroxaban (2.5mg)
Overview Unclot 2.5 Tablet
ThromboGuard 2.5mg tablets are an anticoagulant medication, functioning as a blood thinner. This medication prevents and treats blood clots, mitigating the risk of stroke and heart attack. It's effective in preventing and resolving clot formation in leg, lung, brain, and heart veins. ThromboGuard 2.5mg is frequently prescribed for individuals with atrial fibrillation to prevent clot development. It also lowers the risk of post-surgical clotting in patients following knee or hip replacement. It can be administered with or without food, ideally at the same time daily for optimal efficacy. Long-term use, potentially lifelong, may be necessary. Discontinuing or altering dosage without physician consultation is strongly discouraged; doing so significantly increases the risk of stroke, heart attack, or thrombosis. Lifestyle modifications—such as cessation of smoking, adopting a healthy diet, regular exercise, and weight management as needed—further reduce clotting risk. The most prevalent side effect is increased bleeding tendency (e.g., nosebleeds, bruising). Report any unusual symptoms promptly to your physician. This medication is contraindicated for patients with severe hepatic or renal impairment, active bleeding, or concurrent use of other anticoagulants. Breastfeeding is not recommended during treatment. Unlike many anticoagulants, routine PT-INR monitoring is not typically required.
Primary Ingredients of Unclot 2.5 Tablet
There is no text provided to rephrase.
Uses of Unclot 2.5 Tablet
Preventing and managing blood clots
Major Benefits of Unclot 2.5 Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Unclot 2.5 Tablet can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Unclot 2.5 Tablet:
- Bleeding
How to use Unclot 2.5 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Unclot 2.5. Ingest the tablet whole; avoid chewing, crushing, or breaking it. This medication can be taken with or without food, though consistent timing is recommended.
How Unclot 2.5 Tablet works:
Xafix 2.5mg tablets represent a new class of oral blood thinners. Their mechanism involves the selective inhibition of factor Xa, thereby reducing blood clot development.
SAFETY ADVICE
AlcoholCAUTION
Use of alcohol with Unclot 2.5 Tablet requires careful consideration. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
The use of Unclot 2.5 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Unclot 2.5 Tablet while breastfeeding is likely inadvisable. Available data from human studies indicate a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by Unclot 2.5 Tablet, which can induce dizziness or fainting. Side effects from Unclot 2.5 Tablet may impact your capacity to operate a vehicle.
KidneyCAUTION
Patients with kidney impairment should use Unclot 2.5 mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Unclot 2.5 mg tablets are contraindicated in individuals with severe kidney disease.
LiverUNSAFE
Patients with liver conditions should likely refrain from using Unclot 2.5 Tablet due to potential safety concerns. Medical advice is recommended.
What if you forget to take Unclot 2.5 Tablet :
Should you forget a Unclot 2.5 Tablet dose, ingest it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Unclot 2.5 Tablet
| Label | Value |
|---|---|
| Chemical Type | Morpholine-thiophene derivatives |
| Developing Good Habits | No. |
| Treatment Category | KINSHIP |
| Behavioral Class | Factor Xa Inhibitors (Oral) |



